{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:50:36Z","timestamp":1794484236455,"version":"4.9.1"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.phrs.2015.09.007","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T05:13:24Z","timestamp":1443244404000},"page":"81-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Cardiovascular drugs-induced oral toxicities: A murky area to be revisited and illuminated"],"prefix":"10.1016","volume":"102","author":[{"given":"Pitchai","family":"Balakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthu","family":"Kavitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Nanditha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2015.09.007_bib0005","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.cellsig.2014.06.011","article-title":"A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology","volume":"26","author":"Balakumar","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.phrs.2015.09.007_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.oooo.2014.09.009","article-title":"Adverse drug events in the oral cavity","volume":"119","author":"Yuan","year":"2015","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0015","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1601-0825.2010.01686.x","article-title":"Potential oral manifestations of cardiovascular drugs","volume":"16","author":"Habbab","year":"2010","journal-title":"Oral Dis."},{"key":"10.1016\/j.phrs.2015.09.007_bib0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/154411130401500104","article-title":"Oral adverse drug reactions to cardiovascular drugs","volume":"15","author":"Torpet","year":"2004","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"10.1016\/j.phrs.2015.09.007_bib0025","series-title":"Chapter 36: Pathophysiology and Pharmacotherapy of Cardiovascular Disease","first-page":"751","article-title":"Drugs targeting RAAS in the treatment of hypertension and other cardiovascular diseases","author":"Balakumar","year":"2015"},{"key":"10.1016\/j.phrs.2015.09.007_bib0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/0378-6323.13789","article-title":"Amiodarone-induced angioedema: report of two cases","volume":"71","author":"Lahiri","year":"2005","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/ageing\/29.4.372","article-title":"Major aphthous ulcers induced by nicorandil","volume":"29","author":"Gupta","year":"2000","journal-title":"Age Ageing"},{"key":"10.1016\/j.phrs.2015.09.007_bib0040","first-page":"195","article-title":"Loss of taste with clopidogrel","volume":"54","author":"Cave","year":"2008","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.phrs.2015.09.007_bib0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/TCRM.S23889","article-title":"Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor","volume":"7","author":"Ali","year":"2011","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.phrs.2015.09.007_bib0050","first-page":"CD009603","article-title":"Interventions for the management of dry mouth: non-pharmacological interventions","volume":"9","author":"Furness","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2015.09.007_bib0055","unstructured":"PubMed Health Non-drug treatments for dry mouth symptoms. http:\/\/www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0058555\/ accessed 21.01.15."},{"issue":"Suppl","key":"10.1016\/j.phrs.2015.09.007_bib0060","first-page":"1","article-title":"Xerostomia prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists","volume":"116","author":"Nederfors","year":"1996","journal-title":"Swed. Dent. J."},{"key":"10.1016\/j.phrs.2015.09.007_bib0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14219\/jada.archive.2003.0018","article-title":"Xerostomia etiology, recognition and treatment","volume":"134","author":"Guggenheimer","year":"2003","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.phrs.2015.09.007_bib0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1601-0825.2003.03967.x","article-title":"Drug effects on salivary glands: dry mouth","volume":"9","author":"Scully","year":"2003","journal-title":"Oral Dis."},{"key":"10.1016\/j.phrs.2015.09.007_bib0075","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3109\/10641969909061015","article-title":"Centrally acting antihypertensive drugs. Present and future","volume":"21","author":"van Zwieten","year":"1999","journal-title":"Clin. Exp. Hypertens."},{"issue":"Suppl","key":"10.1016\/j.phrs.2015.09.007_bib0080","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00004872-199715011-00001","article-title":"Centrally acting antihypertensives: a renaissance of interest. Mechanisms and haemodynamics","volume":"15","author":"van Zwieten","year":"1997","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2015.09.007_bib0085","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1464-410X.1997.00411.x","article-title":"Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses","volume":"80","author":"Lee","year":"1997","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0090","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0722.1996.tb00076.x","article-title":"Effects on salivary flow rate and composition of withdrawal of and re-exposure to the beta 1-selective antagonist metoprolol in a hypertensive patient population","volume":"104","author":"Nederfors","year":"1996","journal-title":"Eur. J. Oral Sci."},{"key":"10.1016\/j.phrs.2015.09.007_bib0095","first-page":"91","article-title":"Hospital intensive monitoring of adverse reactions of ACE inhibitors","volume":"89","author":"Mangrella","year":"1998","journal-title":"Minerva Med."},{"key":"10.1016\/j.phrs.2015.09.007_bib0100","unstructured":"http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/020738s029lbl.pdf. Accessed 23.01.15."},{"key":"10.1016\/j.phrs.2015.09.007_bib0105","unstructured":"http:\/\/www.rxlist.com\/cozaar-side-effects-drug-center.htm. Accessed 23.01.15."},{"key":"10.1016\/j.phrs.2015.09.007_bib0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1741-2358.1989.tb00398.x","article-title":"Effects of furosemide on the oral cavity","volume":"8","author":"Atkinson","year":"1989","journal-title":"Gerodontology"},{"key":"10.1016\/j.phrs.2015.09.007_bib0115","first-page":"520","article-title":"Effects of the thiazide diuretic bendroflumethiazide on salivary flow rate and composition","volume":"97","author":"Nederfors","year":"1989","journal-title":"Scand. J. Dent. Res."},{"key":"10.1016\/j.phrs.2015.09.007_bib0120","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.archoralbio.2004.01.007","article-title":"Effects of furosemide and bendroflumethiazide on saliva flow rate and composition","volume":"49","author":"Nederfors","year":"2004","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4103\/2141-9248.139311","article-title":"Effect of diuretics on salivary flow, composition and oral health status: a clinico-biochemical study","volume":"4","author":"Prasanthi","year":"2014","journal-title":"Ann. Med. Health Sci. Res."},{"key":"10.1016\/j.phrs.2015.09.007_bib0130","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/BF01300391","article-title":"Effect of verapamil on human intestinal transit","volume":"37","author":"Krevsky","year":"1992","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2015.09.007_bib0135","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.lfs.2007.07.005","article-title":"Calcium antagonists cause dry mouth by inhibiting resting saliva secretion","volume":"81","author":"Hattori","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2015.09.007_bib0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40496-014-0022-y","article-title":"Understanding the pathobiology of oral lichen planus","volume":"1","author":"Carrozzo","year":"2014","journal-title":"Curr. Oral Health Rep."},{"key":"10.1016\/j.phrs.2015.09.007_bib0145","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cden.2014.01.001","article-title":"Oral lichen planus and lichenoid mucositis","volume":"58","author":"De","year":"2014","journal-title":"Dent. Clin. North Am."},{"key":"10.1016\/j.phrs.2015.09.007_bib0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1600-0714.2010.00897.x","article-title":"Can the genotype or phenotype of two polymorphic drug metabolising cytochrome P450-enzymes identify oral lichenoid drug eruptions?","volume":"39","author":"Kragelund","year":"2010","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.phrs.2015.09.007_bib0155","first-page":"73","article-title":"Oral lichenoid drug reaction associated with antihypertensive and hypoglycemic drugs","volume":"9","author":"Kaomongkolgit","year":"2010","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0160","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2165\/11634590-000000000-00000","article-title":"Lichen planus-like drug eruptions due to \u03b2-blockers: a case report and literature review","volume":"13","author":"Fessa","year":"2012","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/j.1875-9114.1994.tb02852.x","article-title":"Drug-induced lichen planus","volume":"14","author":"Thompson","year":"1994","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.phrs.2015.09.007_bib0170","first-page":"122","article-title":"Severe oral erosive lichen planus due to methyldopa and allopurinol: a case report","volume":"2","author":"Nair","year":"2005","journal-title":"Hong Kong Dent. J."},{"key":"10.1016\/j.phrs.2015.09.007_bib0175","unstructured":"http:\/\/www.ehealthme.com\/ds\/amlodipine+besylate\/oral+lichen+planus. Accessed 04.02.15."},{"key":"10.1016\/j.phrs.2015.09.007_bib0180","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1529-8019.2010.01324.x","article-title":"Aphthous ulcers","volume":"23","author":"Messadi","year":"2010","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.phrs.2015.09.007_bib0185","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.4317\/jced.51227","article-title":"Prevalence of recurrent aphthous ulceration in the Indian population","volume":"6","author":"Patil","year":"2014","journal-title":"J. Clin. Exp. Dent."},{"key":"10.1016\/j.phrs.2015.09.007_bib0190","unstructured":"http:\/\/www.patient.co.uk\/health\/aphthous-mouth-ulcers. Accessed 26.02.15."},{"key":"10.1016\/j.phrs.2015.09.007_bib0195","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/moe.2001.110306","article-title":"Nicorandil can induce severe oral ulceration","volume":"91","author":"Scully","year":"2001","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.phrs.2015.09.007_bib0200","first-page":"157","article-title":"Nicorandil-induced severe oral ulceration","volume":"50","author":"O'Sullivan","year":"2004","journal-title":"J. Ir. Dent. Assoc."},{"key":"10.1016\/j.phrs.2015.09.007_bib0205","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s10266-011-0015-4","article-title":"Nicorandil-induced tongue ulceration with or without fungal infection","volume":"100","author":"Terai","year":"2012","journal-title":"Odontology"},{"key":"10.1016\/j.phrs.2015.09.007_bib0210","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1046\/j.1365-2133.2000.03898.x","article-title":"Role of drug exposure in aphthous ulcers: a case-control study","volume":"143","author":"Boulinguez","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0215","first-page":"695","article-title":"Aphthoid stomatitis induced by labetalol","volume":"37","author":"Pradalier","year":"1982","journal-title":"Therapie"},{"key":"10.1016\/j.phrs.2015.09.007_bib0220","doi-asserted-by":"crossref","first-page":"659","DOI":"10.7326\/0003-4819-94-5-659","article-title":"Ulceration of the tongue: a complication of captopril therapy","volume":"94","author":"Nicholls","year":"1981","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2015.09.007_bib0225","first-page":"197","article-title":"Aphtous ulcers of the mouth associated with losartan","volume":"50","author":"Goffin","year":"1998","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0230","first-page":"97","article-title":"Stomatitis and ageusia induced by candesartan","volume":"25","author":"Chen","year":"2004","journal-title":"Nephrologie"},{"key":"10.1016\/j.phrs.2015.09.007_bib0235","first-page":"62","article-title":"Irbesartan-induced aphthous stomatitis","volume":"2","author":"Manunza","year":"2015","journal-title":"Global Dermatol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0240","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.14219\/jada.archive.1999.0100","article-title":"Recalcitrant oral ulcers caused by calcium channel blockers: diagnosis and treatment considerations","volume":"130","author":"Cohen","year":"1999","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.phrs.2015.09.007_bib0245","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.4076\/1757-1626-2-7181","article-title":"ACE-I induced angioedema: a case report and review of literature","volume":"2","author":"Adebayo","year":"2009","journal-title":"Cases J."},{"key":"10.1016\/j.phrs.2015.09.007_bib0250","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1524-6175.2002.01509.x","article-title":"ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used?","volume":"4","author":"Sica","year":"2002","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.phrs.2015.09.007_bib0255","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jaad.2004.09.032","article-title":"Angioedema","volume":"53","author":"Kaplan","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0260","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2332\/allergolint.12-RAI-0493","article-title":"Recent advances in drug-induced angioedema","volume":"61","author":"Inomata","year":"2012","journal-title":"Allergol. Int."},{"key":"10.1016\/j.phrs.2015.09.007_bib0265","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s001010050225","article-title":"Life-threatening postoperative angioedema following treatment with an angiotensin converting enzyme inhibitor","volume":"44","author":"Maier","year":"1995","journal-title":"Anaesthesist"},{"key":"10.1016\/j.phrs.2015.09.007_bib0270","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/archinte.161.20.2417","article-title":"Hereditary angioedema: a broad review for clinicians","volume":"161","author":"Nzeako","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.phrs.2015.09.007_bib0275","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0828-282X(07)70762-6","article-title":"Late-onset angioedema due to an angiotensin-converting enzyme inhibitor","volume":"23","author":"Garcia-Pavia","year":"2007","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0280","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1253\/jcj.60.166","article-title":"A case report of angioedema during long-term (66 months) angiotensin converting enzyme inhibition therapy with enalapril","volume":"60","author":"Shionoiri","year":"1996","journal-title":"Jpn. Circ. J."},{"key":"10.1016\/j.phrs.2015.09.007_bib0285","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jama.1997.03550030072037","article-title":"Recurrent angiotensin-converting enzyme inhibitor\u2014associated angioedema","volume":"278","author":"Brown","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2015.09.007_bib0290","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/01.CIR.0000153269.07762.3B","article-title":"Losartan increases bradykinin levels in hypertensive humans","volume":"111","author":"Campbell","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2015.09.007_bib0295","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1592\/phco.22.13.1176.33516","article-title":"Angioedema associated with candesartan","volume":"22","author":"Lo","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.phrs.2015.09.007_bib0300","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1345\/aph.1C520","article-title":"Valsartan-induced angioedema","volume":"37","author":"Irons","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.phrs.2015.09.007_bib0305","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1345\/aph.1H566","article-title":"Olmesartan medoxomil-induced angioedema","volume":"41","author":"Nykamp","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.phrs.2015.09.007_bib0310","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2015.09.007_bib0315","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.cellsig.2012.04.003","article-title":"How well do aliskiren\u2019s purported mechanisms track its effects on cardiovascular and renal disorders?","volume":"24","author":"Jagadeesh","year":"2012","journal-title":"Cell Signal"},{"key":"10.1016\/j.phrs.2015.09.007_bib0320","doi-asserted-by":"crossref","unstructured":"http:\/\/www.bmj.com\/content\/345\/bmj.e6941 long. Incidence of angio-oedema associated with ARBs, ACE inhibitors, and aliskiren. BMJ 2012, 345, e6941.","DOI":"10.1136\/bmj.e6941"},{"key":"10.1016\/j.phrs.2015.09.007_bib0325","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1081-1206(10)60860-5","article-title":"Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"98","author":"Malde","year":"2007","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0330","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1445-5994.2002.00286.x","article-title":"Renin-angiotensin system inhibition: how much is too much of a good thing?","volume":"32","author":"Campbell","year":"2002","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.phrs.2015.09.007_bib0335","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1378\/chest.106.6.1922","article-title":"Angioedema following the intravenous administration of metoprolol","volume":"106","author":"Krikorian","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.phrs.2015.09.007_bib0340","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2146\/ajhp090120","article-title":"Propranolol-induced angioedema in a patient with chronic hepatitis C virus infection","volume":"67","author":"M\u00e1rquez-Saavedra","year":"2010","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.phrs.2015.09.007_bib0345","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","article-title":"Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system","volume":"172","author":"Toh","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.phrs.2015.09.007_bib0350","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1345\/aph.1L527","article-title":"Probable amlodipine-induced angioedema","volume":"43","author":"Southward","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.phrs.2015.09.007_bib0355","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2146\/ajhp100277","article-title":"Angioedema associated with dihydropyridine calcium-channel blockers in a child with Burkitt lymphoma","volume":"68","author":"Pierce","year":"2011","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.phrs.2015.09.007_bib0360","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jacc.2011.06.040","article-title":"Characterization of clopidogrel hypersensitivity reactions and management with oral steroids without clopidogrel discontinuation","volume":"58","author":"Cheema","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0365","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1034\/j.1398-9995.2000.00824.x","article-title":"Amiodarone-induced angioedema","volume":"55","author":"Burches","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.phrs.2015.09.007_bib0370","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0301-0546(03)79210-6","article-title":"Anaphylaxis to oral furosemide","volume":"31","author":"Dom\u00ednguez-Ortega","year":"2003","journal-title":"Allergol. Immunopathol. (Madr)"},{"key":"10.1016\/j.phrs.2015.09.007_bib0375","first-page":"CD010470","article-title":"Interventions for the management of taste disturbances","volume":"11","author":"Nagraj","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2015.09.007_bib0380","doi-asserted-by":"crossref","first-page":"017105","DOI":"10.1088\/1752-7155\/6\/1\/017105","article-title":"Breaking paradigms: a new definition for halitosis in the context of pseudo-halitosis and halitophobia","volume":"6","author":"Falc\u00e3o","year":"2012","journal-title":"J. Breath Res."},{"key":"10.1016\/j.phrs.2015.09.007_bib0385","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/00004872-200310000-00003","article-title":"Influences of antihypertensive and antihyperlipidemic drugs on the senses of taste and smell: a review","volume":"21","author":"Doty","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2015.09.007_bib0390","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/bmj.296.6629.1086","article-title":"Eye pain with nifedipine and disturbance of taste with captopril: a mutually controlled study showing a method of postmarketing surveillance","volume":"296","author":"Coulter","year":"1988","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.phrs.2015.09.007_bib0395","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0140-6736(93)91850-L","article-title":"Captopril-induced taste disturbance","volume":"342","author":"Boyd","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2015.09.007_bib0400","first-page":"177","article-title":"Clinical experience with lisinopril. Observations on safety and tolerability","volume":"3","author":"Cameron","year":"1989","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.phrs.2015.09.007_bib0405","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/clc.4960141805","article-title":"Safety profile of benazepril in essential hypertension","volume":"14","author":"MacNab","year":"1991","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0410","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0167-5273(89)90075-2","article-title":"High-risk patients treated with enalapril maleate: safety considerations","volume":"22","author":"Rucinska","year":"1989","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0415","unstructured":"http:\/\/www.medsafe.govt.nz\/profs\/datasheet\/c\/capotentabsol.pdf. Accessed 12.04.15."},{"key":"10.1016\/j.phrs.2015.09.007_bib0420","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1365-2125.2003.02063.x","article-title":"Subclinical alteration of taste sensitivity induced by candesartan in healthy subjects","volume":"57","author":"Tsuruoka","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0425","doi-asserted-by":"crossref","first-page":"72","DOI":"10.7326\/0003-4819-129-1-199807010-00023","article-title":"Reversible dysgeusia attributed to losartan","volume":"129","author":"Heeringa","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2015.09.007_bib0430","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/bmj.325.7375.1277","article-title":"Drug points: dysgeusia and burning mouth syndrome by eprosartan","volume":"325","author":"Castells","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2015.09.007_bib0435","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2125.2005.02394.x","article-title":"Angiotensin II. receptor blocker-induces blunted taste sensitivity: comparison of candesartan and valsartan","volume":"60","author":"Tsuruoka","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0440","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2125.2006.02727.x","article-title":"Dysgeusia with amlodipine\u2014a case report","volume":"63","author":"Sadasivam","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0445","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1345\/aph.1E171","article-title":"Taste and smell disturbance with the alpha-adrenoceptor agonist midodrine","volume":"38","author":"Young","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.phrs.2015.09.007_bib0450","first-page":"1424","article-title":"Research, Science and Therapy Committee, American Academy of Periodontology. Drug-associated gingival enlargement","volume":"75","author":"Dongari-Bagtzoglou","year":"2004","journal-title":"J. Periodontol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0455","first-page":"387","article-title":"An increase in gingival volume induced by drugs (phenytoin, cyclosporine and calcium antagonists). A review of the literature","volume":"47","author":"Garzino-Demo","year":"1998","journal-title":"Minerva Stomatol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0460","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-204670","article-title":"Phenytoin-induced gingival enlargement","volume":"2014","author":"Chacko","year":"2014","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.phrs.2015.09.007_bib0465","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/jhh.2013.47","article-title":"Calcium channel blocker-induced gingival enlargement","volume":"28","author":"Livada","year":"2014","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.phrs.2015.09.007_bib0470","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1754-4505.1991.tb00828.x","article-title":"Gingival hyperplasia: a side effect of nifedipine and diltiazem","volume":"11","author":"Fattore","year":"1991","journal-title":"Spec. Care Dent."},{"key":"10.1016\/j.phrs.2015.09.007_bib0475","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1902\/jop.1985.56.4.211","article-title":"Nifedipine-induced gingival hyperplasia: a histochemical and ultrastructural study","volume":"56","author":"Lucas","year":"1985","journal-title":"J. Periodontol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0480","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1902\/jop.1987.58.9.639","article-title":"Gingival hyperplasia caused by nifedipine. Histopathologic findings","volume":"58","author":"Barak","year":"1987","journal-title":"J. Periodontol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0485","first-page":"741402","article-title":"Nonsurgical management of nifedipine induced gingival overgrowth","volume":"2014","author":"Sam","year":"2014","journal-title":"Case Rep. Dent."},{"key":"10.1016\/j.phrs.2015.09.007_bib0490","first-page":"E480","article-title":"Amlodipine-induced gingival hyperplasia","volume":"11","author":"Lafzi","year":"2006","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"key":"10.1016\/j.phrs.2015.09.007_bib0495","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.ijcard.2006.11.066","article-title":"Amlodipine induced gingival hyperplasia: a rare entity","volume":"122","author":"Bhatia","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0500","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0002-8703(92)90630-E","article-title":"Verapamil-induced gingival hyperplasia in children","volume":"124","author":"Mehta","year":"1992","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2015.09.007_bib0505","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0714.1991.tb00896.x","article-title":"Felodipine-induced gingival hyperplasia: a clinical and histologic study","volume":"20","author":"Lombardi","year":"1991","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.phrs.2015.09.007_bib0510","first-page":"41","article-title":"Felodipine-induced gingival hyperplasia","volume":"62","author":"Young","year":"1998","journal-title":"Cutis"},{"key":"10.1016\/j.phrs.2015.09.007_bib0515","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0035-1768(04)72311-6","article-title":"Nicardipine-induced gingival hyperplasia: case report","volume":"105","author":"Maguin","year":"2004","journal-title":"Rev. Stomatol. Chir. Maxillofac."},{"key":"10.1016\/j.phrs.2015.09.007_bib0520","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0030-4220(90)90406-I","article-title":"Nitrendipine-induced gingival hyperplasia. First case report","volume":"70","author":"Brown","year":"1990","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0525","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1079-2104(97)90316-4","article-title":"Scalded mouth syndrome caused by angiotensin converting enzyme inhibitors: two case reports","volume":"83","author":"Brown","year":"1997","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.phrs.2015.09.007_bib0530","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1136\/bmj.284.6330.1672","article-title":"Scalded mouth caused by angiotensin-converting-enzyme inhibitors","volume":"284","author":"Vlasses","year":"1982","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.phrs.2015.09.007_bib0535","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1177\/106002809202601109","article-title":"Lisinopril-induced scalded mouth syndrome","volume":"26","author":"Savino","year":"1992","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.phrs.2015.09.007_bib0540","first-page":"197","article-title":"Cheilitis due to treatment with simvastatin","volume":"62","author":"Mehregan","year":"1998","journal-title":"Cutis"},{"key":"10.1016\/j.phrs.2015.09.007_bib0545","unstructured":"http:\/\/www.ehealthme.com\/ds\/phenytoin\/cheilitis. Accessed 17.04.15."},{"key":"10.1016\/j.phrs.2015.09.007_bib0550","first-page":"452","article-title":"Nicorandil induced oral ulceration","volume":"32","author":"Farah","year":"2003","journal-title":"Aust. Fam. Physician"},{"key":"10.1016\/j.phrs.2015.09.007_bib0555","first-page":"24","article-title":"A multicenter trial of enalapril in the treatment of essential hypertension","volume":"9","author":"Gavras","year":"1986","journal-title":"Clin. Ther."},{"key":"10.1016\/j.phrs.2015.09.007_bib0560","first-page":"215","article-title":"Pemphigus vulgaris: recent advances in our understanding of its pathogenesis","volume":"56","author":"Femiano","year":"2007","journal-title":"Minerva Stomatol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0565","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00508-013-0382-7","article-title":"Oral bullous eruption after taking lisinopril\u2014case report and literature review","volume":"125","author":"Bari\u010devi\u0107","year":"2013","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.phrs.2015.09.007_bib0570","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0190-9622(92)70057-M","article-title":"Drug-induced pemphigus related to angiotensin-converting enzyme inhibitors","volume":"26","author":"Kaplan","year":"1992","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0575","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1440-0960.2000.00445.x","article-title":"Drug-related pemphigus and angiotensin converting enzyme inhibitors","volume":"41","author":"Ong","year":"2000","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0580","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.atherosclerosis.2009.03.037","article-title":"Oral infection-inflammatory pathway, periodontitis, is a risk factor for endothelial dysfunction in patients with coronary artery disease","volume":"206","author":"Higashi","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2015.09.007_bib0585","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/eci.12322","article-title":"The implication of periodontitis in vascular endothelial dysfunction","volume":"44","author":"Gurav","year":"2014","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.phrs.2015.09.007_bib0590","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tox.2007.12.011","article-title":"Potential target sites to modulate vascular endothelial dysfunction: current perspectives and future directions","volume":"245","author":"Balakumar","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.phrs.2015.09.007_bib0595","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/j.1476-5381.2012.01938.x","article-title":"Submaximal PPAR\u03b3 activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders","volume":"166","author":"Balakumar","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0600","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yjmcc.2011.09.014","article-title":"Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?","volume":"52","author":"Balakumar","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0605","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.freeradbiomed.2012.05.005","article-title":"Fish oil and vascular endothelial protection: bench to bedside","volume":"53","author":"Balakumar","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2015.09.007_bib0610","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bmj.306.6879.688","article-title":"Dental disease and risk of coronary heart disease and mortality","volume":"306","author":"DeStefano","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2015.09.007_bib0615","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/HYPERTENSIONAHA.107.101535","article-title":"Periodontal infection is associated with endothelial dysfunction in healthy subjects and hypertensive patients","volume":"51","author":"Higashi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2015.09.007_bib0620","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4330\/wjc.v7.i1.26","article-title":"Relationship between vascular endothelium and periodontal disease in atherosclerotic lesions: review article","volume":"7","author":"Saffi","year":"2015","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.phrs.2015.09.007_bib0625","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12903-015-0026-6","article-title":"Pathological periodontal pockets are associated with raised diastolic blood pressure in obese adolescents","volume":"15","author":"Zeigler","year":"2015","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.phrs.2015.09.007_bib0630","unstructured":"http:\/\/www.patient.co.uk\/doctor\/dry-mouth-xerostomia. Accessed 22.04.15."},{"key":"10.1016\/j.phrs.2015.09.007_bib0635","unstructured":"http:\/\/www.oralcancerfoundation.org\/complications\/xerostomia.php. Accessed 22.04.15."},{"key":"10.1016\/j.phrs.2015.09.007_bib0640","series-title":"Carranza\u2019s Clinical Periodontology","first-page":"260","author":"Newman","year":"2015"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181500211X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181500211X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T11:25:01Z","timestamp":1718105101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366181500211X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":128,"alternative-id":["S104366181500211X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2015.09.007","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular drugs-induced oral toxicities: A murky area to be revisited and illuminated","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2015.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}